SCHEMBL7639741

SCHEMBL7639741

O=C(CC(CCN1C(=O)c2cccc3c(Br)ccc(c23)C1=O)C(=O)O)c1ccc(-c2ccc(Cl)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 9/20 0.47
MMP2 P08253 6/20 0.45
MMP9 P14780 6/20 0.45
MMP3 P08254 3/20 0.44
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
POLB P06746 3/20 0.44
MMP13 P45452 2/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPC1 O15118 1/20 0.44
PABPC1 P11940 1/20 0.44
MMP1 P03956 1/20 0.44
MMP8 P22894 1/20 0.44
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7378575 0.85 MMP2 (0.59) MMP2MMP9MMP3MMP13MMP1
SCHEMBL7347186 0.85 MMP2 (0.59) MMP2MMP9MMP3MMP13MMP1
SCHEMBL4654577 0.85 MMP2 (0.59) MMP2MMP9MMP3MMP13MMP1
SCHEMBL2380986 0.79 MMP2 (0.61) MMP2MMP9MMP3MMP13KMT2A
SCHEMBL12300384 0.79 MMP2 (0.61) MMP2MMP9MMP3MMP13KMT2A
SCHEMBL9248117 0.79 MMP2 (0.61) MMP2MMP9MMP3MMP13KMT2A
SCHEMBL6296089 0.79 GSK3B (0.55) MMP2MMP9MMP3POLBMMP13
SCHEMBL6291932 0.76 MMP2 (0.48) MMP2MMP9MMP3ALDH1A1MMP13
SCHEMBL7861873 0.75 GSK3B (0.59) MMP2MMP9MMP3ALDH1A1MAPT
SCHEMBL6376234 0.75 MMP2 (0.44) MMP2MMP9MMP3ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790974-B1 SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS BAYER AG (US) 2002-08-14 EP claimed
EP-0790974-B1 SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS BAYER AG (US) 2002-08-14 EP disclosed
US-6166082-A Substituted 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors BAYER CORPORATION (US) 2000-12-26 US disclosed